The FDA approves zanidatamab for HER2-positive biliary cancer, improving treatment options.
Teny Khachadourian, PharmD Candidate
Advertisement
Articles by Teny Khachadourian, PharmD Candidate
The significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacy Is a Practice, Not Just a Place
2
Beyond mRNA: A Pharmacist’s Guide to the Full COVID-19 Vaccine Landscape
3
Beat the Heat: 10 Common Medication Culprits Causing Heat Intolerance
4
Yes, COVID-19 Is Still a Big Deal. Pharmacy Is the Tip of the Spear (and Needle)
5